Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis.

Literature DB >> 17437672

Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis.

Abstract

Glucocorticoid-induced osteoporosis is a common but still relatively neglected problem, with a low level of awareness among primary and secondary care physicians. Fractures appear early after initiation of treatment, and effective prophylaxis requires primary prevention in those at high risk of fracture. Bisphosphonates are the treatment of choice, and calcium and vitamin D supplements are also indicated in the majority of individuals. Organized care programs together with the use of evidence-based guidelines have the potential to improve significantly the management of this serious complication of glucocorticoid therapy.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17437672 DOI： 10.1007/s11926-007-0026-x

Source DB: PubMed Journal: Curr Rheumatol Rep ISSN： 1523-3774 Impact factor: 4.592

47 in total

1. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

Authors: Hajime Nawata; Satoshi Soen; Ryoichi Takayanagi; Ikuko Tanaka; Kunio Takaoka; Masao Fukunaga; Toshio Matsumoto; Yasuo Suzuki; Hiroyuki Tanaka; Saeko Fujiwara; Takami Miki; Akira Sagawa; Yoshiki Nishizawa; Yoshiki Seino
Journal: J Bone Miner Metab Date: 2005 Impact factor: 2.626

2. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.

Authors: Adrianne C Feldstein; Patricia J Elmer; Gregory A Nichols; Michael Herson
Journal: Osteoporos Int Date: 2005-09-03 Impact factor: 4.507

Review 3. Use of oral corticosteroids and risk of fractures.

Authors: T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal: J Bone Miner Res Date: 2000-06 Impact factor: 6.741

4. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.

Authors: I Lambrinoudaki; D T Chan; C S Lau; R W Wong; S S Yeung; A W Kung
Journal: J Rheumatol Date: 2000-07 Impact factor: 4.666

Review 5. Glucocorticoid-induced osteoporosis: an update.

Authors: Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Journal: Trends Endocrinol Metab Date: 2006 May-Jun Impact factor: 12.015

6. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.

Authors: H U Stempfle; C Werner; S Echtler; U Wehr; W A Rambeck; U Siebert; P Uberfuhr; C E Angermann; K Theisen; R Gärtner
Journal: Transplantation Date: 1999-08-27 Impact factor: 4.939

7. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium.

Authors: J D Ringe; A Cöster; T Meng; E Schacht; R Umbach
Journal: Calcif Tissue Int Date: 1999-10 Impact factor: 4.333

8. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.

Authors: P Lakatos; Z Nagy; L Kiss; C Horvath; I Takacs; J Foldes; G Speer; A Bossanyi
Journal: Z Rheumatol Date: 2000 Impact factor: 1.372

9. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate.

Authors: J Herrala; H Puolijoki; O Impivaara; K Liippo; E Tala; M M Nieminen
Journal: Bone Date: 1994 Nov-Dec Impact factor: 4.398

Review 10. Diagnosis of osteoporosis and assessment of fracture risk.

Authors: John A Kanis
Journal: Lancet Date: 2002-06-01 Impact factor: 79.321

17 in total

Review 1. Strategies for minimizing corticosteroid toxicity: a review.

Authors: Roosy Aulakh; Surjit Singh
Journal: Indian J Pediatr Date: 2008-11-21 Impact factor: 1.967

2. An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.

Authors: L Caplan; A E Hines; E Williams; A V Prochazka; K G Saag; F Cunningham; E Hutt
Journal: Osteoporos Int Date: 2010-04-01 Impact factor: 4.507

3. Treatment of glucocorticoid-induced osteoporsis.

Authors: Gherardo Mazziotti; Andrea Giustina; Ernesto Canalis; John P Bilezikian
Journal: Ther Adv Musculoskelet Dis Date: 2009-02 Impact factor: 5.346

Review 4. Management of glucocorticoid-induced osteoporosis.

Authors: Juliet Compston
Journal: Nat Rev Rheumatol Date: 2010-02 Impact factor: 20.543

Review 5. Autophagy as a target for glucocorticoid-induced osteoporosis therapy.

Authors: Gengyang Shen; Hui Ren; Qi Shang; Ting Qiu; Xiang Yu; Zhida Zhang; Jinjing Huang; Wenhua Zhao; Yuzhuo Zhang; Xiaobing Jiang
Journal: Cell Mol Life Sci Date: 2018-02-09 Impact factor: 9.261

6. Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study.

Authors: U Massafra; S Migliaccio; C Bancheri; F Chiacchiararelli; F Fantini; F Leoni; L S Martin; A Migliore; B Muccifora; C Napolitano; R Pastore; A Ragno; S Ronzoni; M Rotondi; M Tibaldi; P Villa; V Vinicola; E D'Erasmo; P Falaschi; G Minisola
Journal: J Endocrinol Invest Date: 2012-03-06 Impact factor: 4.256

10. Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway.

Authors: Congshan Li; Panpan Yang; Bo Liu; Jie Bu; Hongrui Liu; Jie Guo; Tomoka Hasegawa; Haipeng Si; Minqi Li
Journal: J Mol Histol Date: 2021-07-23 Impact factor: 2.611